Final analysis of the Phase 3 trial shows the drug is more than...
Pfizer and partner BioNTech said they have submitted a request on Friday to the U.S. Food and Drug Administration for emergency use authorization of their Covid-19 vaccine candidate.
“It is with great pride and joy, and even a little relief, but I can say that our request for emergency use authorisation for our Covid-19 vaccine is now in the FDA’s hands,” Dr. Albert...